Advanced Search

Study Preview



Study Title and Description

Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.



Key Questions Addressed
1 How do different methods for detection of toxigenic C. difficile to assist with diagnosis of CDI compare in their sensitivity, specificity, and predictive values? a. Overall? b. Do performance measures vary with sample characteristics? c. Does testing strategy impact patient health or health system outcomes?
  • Comments Comments (
    0
    ) |
2 What are effective prevention strategies? a. What is the effectiveness of current prevention strategies? b. What are the harms associated with prevention strategies? c. How sustainable are prevention practices in health care (outpatient, hospital inpatient, extended care) and community settings?
  • Comments Comments (
    0
    ) |
3 What is the comparative effectiveness and harms of different antibiotic treatments? a. Does effectiveness vary by disease severity?
  • Comments Comments (
    0
    ) |
4 What are the effectiveness and harms of other interventions? a. Overall b. In patients with relapse/recurrent CDI.
  • Comments Comments (
    0
    ) |

Primary Publication Information
  • Comments Comments (
    0
    ) |
TitleData
Title Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
Author McFarland LV., Surawicz CM., Greenberg RN., Elmer GW., Moyer KA., Melcher SA., Bowen KE., Cox JL.
Country Department of Medicinal Chemistry, University of Washington, Seattle.
Year 1995
Numbers Pubmed ID: 7872284

Secondary Publication Information
There are currently no secondary publications defined for this study.


Extraction Form: Detection, prevention, treatments, and efficacy and harms of interventions for C. difficile


Results & Comparisons

No Results found.